Your session is about to expire
← Back to Search
Brain Stimulation
Brain Stimulation + Physical Therapy for Parkinson's Disease
N/A
Recruiting
Led By Felipe Fregni, MD, PhD
Research Sponsored by Spaulding Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age from 40 to 90 years old
Be older than 18 years old
Must not have
History of deep brain stimulation or brain ablation surgeries, malignant mass brain lesions
Unstable medical conditions (e.g., uncontrolled diabetes, uncompensated cardiac issues, heart failure, uncompensated pulmonary disease, or chronic obstructive pulmonary disease)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week pre intervention, immediately before intervention, following stimulation treatment (stimulation day 5, 10 and 14), and all follow ups
Summary
This trial is testing whether a combination of transcranial direct current stimulation (tDCS) and transcranial ultrasound (TUS) can help improve postural instability in Parkinson's disease patients receiving physical therapy.
Who is the study for?
This trial is for people aged 40-90 with Parkinson's Disease who have balance issues or postural instability and are on stable PD medications. Excluded are those with other balance-affecting conditions, brain surgeries, metal in the head, severe medical problems, pregnancy, recent PT programs, non-PD parkinsonism syndromes, certain psychiatric or substance abuse histories.
What is being tested?
The study tests if brain stimulation (tDCS) plus ultrasound (TUS), along with physical therapy (PT), can improve stability in Parkinson's patients. It's a double-blind study where participants randomly get either real treatment or sham (fake) versions for two weeks followed by biweekly sessions.
What are the potential side effects?
Potential side effects of tDCS and TUS may include discomfort at the stimulation site, headache, dizziness or nausea during application. However specific risks related to these treatments will be monitored closely throughout the trial.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 40 and 90 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had brain surgery or have malignant brain tumors.
Select...
My medical conditions, like diabetes or heart issues, are under control.
Select...
I have a condition like epilepsy or another that makes seizures more likely.
Select...
I am confined to a bed or wheelchair.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week pre intervention, immediately before intervention, following stimulation treatment (stimulation day 5, 10 and 14), and all follow ups
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week pre intervention, immediately before intervention, following stimulation treatment (stimulation day 5, 10 and 14), and all follow ups
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in postural sway
Secondary study objectives
Arising from a chair
Balance
Gait
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active tDCS and Active TUSExperimental Treatment2 Interventions
Active tDCS and Active TUS for 20 min
Group II: Sham TDCS and Sham TUSPlacebo Group2 Interventions
Sham TDCS and Sham TUS for 20 min
Find a Location
Who is running the clinical trial?
Spaulding Rehabilitation HospitalLead Sponsor
137 Previous Clinical Trials
10,977 Total Patients Enrolled
Highland Instruments, Inc.Industry Sponsor
10 Previous Clinical Trials
513 Total Patients Enrolled
Felipe Fregni, MD, PhDPrincipal Investigator - Spaulding Rehabilitation Hospital
Spaulding Rehabilitation Hospital
5 Previous Clinical Trials
148 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger